- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07745192
Effects of a Lateral Position With Hip Flexion and Femoral Internal Rotation During the Second Stage of Labor in Nulliparous Women Receiving Epidural Analgesia
July 30, 2026 updated by: Second Affiliated Hospital of Wenzhou Medical University
This randomized clinical study evaluated the effects of a lateral position with hip flexion and femoral internal rotation during the second stage of labor in nulliparous women receiving epidural labor analgesia.
Participants were assigned to either an observation group using the modified lateral position or a control group using the conventional lateral position.
The study compared second-stage labor duration, additional obstetric interventions, maternal outcomes, perineal outcomes, and neonatal outcomes between the two groups.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
230
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zhejiang
-
Wenzhou, Zhejiang, China, 325000
- Nanpu Branch of The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Nulliparous women.
- Age 22 to 34 years.
- Singleton pregnancy.
- Cephalic presentation confirmed by ultrasonography after 37 weeks of gestation.
- Gestational age of 37 to 41 weeks.
- Estimated fetal weight of 2,500 to 3,500 g.
- No birth-canal abnormalities on vaginal examination.
- Effective epidural labor analgesia during the first stage of labor.
- Sufficient cognitive capacity to understand and cooperate with the study procedures.
- Ability and willingness to provide written informed consent.
Exclusion Criteria:
- Organic heart, liver, or kidney disease.
- Prenatal indication for cesarean delivery.
- Pubic symphysis separation.
- Lower-limb disease or impaired mobility.
- Precipitous labor.
- Second stage of labor lasting less than 30 minutes.
- Severe mental illness.
- Fetal malformation.
- Withdrawal from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Modified Lateral Position Group
Participants in this group adopted a lateral position with hip flexion and femoral internal rotation during the second stage of labor under midwife assistance.
|
Participants adopted a modified lateral position during the second stage of labor.
The position involved lateral positioning facing the side opposite to the fetal back, hip flexion, knee flexion, and 30°-40° femoral internal rotation with midwife assistance.
The position was used during uterine contractions with guided bearing-down efforts and was alternated with a semi-recumbent position according to the study protocol.
|
|
Active Comparator: Conventional Lateral Position Group
Participants in this group adopted the conventional lateral position during the second stage of labor under routine intrapartum care and midwife
|
Participants adopted the conventional lateral position during the second stage of labor under routine intrapartum care and midwife assistance.
During uterine contractions, participants performed bearing-down efforts in the lateral position, followed by intervals of rest and semi-recumbent positioning according to the study protocol.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of the Second Stage of Labor
Time Frame: From full cervical dilatation to delivery of the neonate
|
From full cervical dilatation to delivery of the neonate
|
|
|
Additional Obstetric Interventions During the Second Stage of Labor
Time Frame: During the second stage of labor
|
Additional obstetric interventions during the second stage of labor, classified as none, forceps-assisted vaginal birth, cesarean delivery during the second stage, vaginal birth after manual fetal-head rotation, or vaginal birth with episiotomy as the principal intervention.
|
During the second stage of labor
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of the First Stage of Labor
Time Frame: From onset of regular uterine contractions to full cervical dilatation
|
Duration of the first stage of labor, measured in minutes.
|
From onset of regular uterine contractions to full cervical dilatation
|
|
Duration of the Third Stage of Labor
Time Frame: From delivery of the neonate to delivery of the placenta
|
Duration of the third stage of labor, measured in minutes.
|
From delivery of the neonate to delivery of the placenta
|
|
Postpartum Blood Loss
Time Frame: Within 2 hours after delivery
|
Postpartum blood loss, measured in milliliters.
|
Within 2 hours after delivery
|
|
Perineal Outcomes
Time Frame: At delivery
|
Perineal outcomes classified as intact perineum, episiotomy, first-degree perineal laceration, or second-degree or higher perineal laceration.
|
At delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2025
Primary Completion (Actual)
December 30, 2025
Study Completion (Actual)
December 30, 2025
Study Registration Dates
First Submitted
July 30, 2026
First Submitted That Met QC Criteria
July 30, 2026
First Posted (Actual)
August 4, 2026
Study Record Updates
Last Update Posted (Actual)
August 4, 2026
Last Update Submitted That Met QC Criteria
July 30, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SAHoWMU-CR2024-07-118
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.